ENERZAIR BREEZHALER 150/50/160 MCG 30 INH. CAPS. + INHALER

GLYCOPYRRONIUM is indicated as a long-term once-daily maintenance bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema. Not for Acute use. INDACATEROL is a long-acting beta 2 -agonist (LABA) indicated for long-term once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.